Clear cell papillary renal cell carcinoma

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's weight loss doctor NYC
Philadelphia GLP-1 weight loss and GLP-1 clinic NYC

Clear cell papillary renal cell carcinoma
Synonyms	Clear cell papillary RCC
Pronounce	N/A
Specialty	N/A
Symptoms	Often asymptomatic, may present with hematuria, flank pain, or a palpable mass
Complications	Rarely metastasizes
Onset	Typically in adults
Duration	Indolent
Types	N/A
Causes	Unknown
Risks	Chronic kidney disease, end-stage renal disease
Diagnosis	Histopathology, immunohistochemistry
Differential diagnosis	Clear cell renal cell carcinoma, papillary renal cell carcinoma
Prevention	N/A
Treatment	Surgical resection
Medication	N/A
Prognosis	Excellent, low risk of progression
Frequency	Rare
Deaths	N/A

Clear cell papillary renal cell carcinoma (ccpRCC) is a distinct subtype of renal cell carcinoma (RCC) characterized by unique histological and genetic features. It was first described in the early 2000s and has since been recognized as a separate entity in the classification of kidney tumors. ccpRCC typically exhibits a favorable prognosis and has unique morphological characteristics that distinguish it from other types of RCC.

Clear cell papillary renal cell carcinoma

Epidemiology

The exact prevalence of ccpRCC is difficult to determine, as it was only relatively recently recognized as a distinct entity. However, it is considered to be a rare subtype of RCC. ccpRCC can occur in individuals of any age but is more commonly diagnosed in adults. There is no clear gender predilection.

Pathogenesis

The pathogenesis of ccpRCC is not fully understood. Unlike the more common clear cell RCC, which is often associated with mutations in the VHL gene, ccpRCC does not typically exhibit mutations in known cancer-associated genes. Its unique genetic and molecular profile suggests a different pathway of carcinogenesis.

Clinical Features

Patients with ccpRCC often present with incidental findings, as these tumors are usually asymptomatic in the early stages. When symptoms do occur, they may include hematuria (blood in the urine), flank pain, or a palpable mass in the abdomen. However, these symptoms are not specific to ccpRCC and can be associated with various renal conditions.

Diagnosis

The diagnosis of ccpRCC is primarily based on histological examination of the tumor tissue. Imaging studies such as ultrasound, computed tomography (CT) scans, and magnetic resonance imaging (MRI) can suggest the presence of a renal mass but cannot definitively diagnose ccpRCC. Histologically, ccpRCC is characterized by clear cells and papillary architecture, with cells arranged in a linear pattern along the basement membrane. Immunohistochemical staining is also used to differentiate ccpRCC from other subtypes of RCC.

Treatment

The treatment for ccpRCC typically involves surgical resection of the tumor. Nephron-sparing surgery, such as partial nephrectomy, is preferred to preserve renal function, especially in cases of small, localized tumors. For more advanced cases, radical nephrectomy may be necessary. The role of adjuvant therapies, such as targeted therapy or immunotherapy, in the treatment of ccpRCC is still under investigation, as this subtype generally exhibits a favorable prognosis and may not require aggressive treatment.

Prognosis

ccpRCC is generally associated with a favorable prognosis, especially when diagnosed at an early stage. The tumor tends to grow slowly and has a low potential for metastasis. The overall survival rate for patients with ccpRCC is higher compared to those with more aggressive subtypes of RCC.

Summary

Clear cell papillary renal cell carcinoma represents a unique subtype of renal cell carcinoma with distinct clinical, histological, and genetic characteristics. Its recognition as a separate entity has implications for diagnosis, treatment, and prognosis of patients with this condition. Ongoing research is necessary to further understand the pathogenesis of ccpRCC and to refine treatment strategies.

   This article is a oncology stub. You can help WikiMD by expanding it!